Endocrine tumours: imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach
L Lamartina, D Deandreis, C Durante… - European Journal of …, 2016 - academic.oup.com
The clinical and epidemiological profiles of differentiated thyroid cancers (DTCs) have
changed in the last three decades. Today's DTCs are more likely to be small, localized …
changed in the last three decades. Today's DTCs are more likely to be small, localized …
Appropriate use criteria for nuclear medicine in the evaluation and treatment of differentiated thyroid cancer
KJ Donohoe, J Aloff, AM Avram… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Nuclear medicine is an essential tool in the delivery of high-quality medical care, going
beyond simple anatomic imaging to the use of physiologic processes for both imaging and …
beyond simple anatomic imaging to the use of physiologic processes for both imaging and …
Preablation diagnostic whole-body scan vs empiric radioactive iodine ablation in differentiated thyroid cancer: cost-effectiveness analysis
S Arjani, PL Quinn, RJ Chokshi - Otolaryngology–Head and …, 2021 - journals.sagepub.com
Objective To perform a comparative analysis of postthyroidectomy radioactive iodine
ablation dosing with or without the implementation of a diagnostic whole-body scan in …
ablation dosing with or without the implementation of a diagnostic whole-body scan in …
Povezanost učestalosti BRAF V600E mutiranih alela sa stupnjem proširenosti papilarnog karcinoma štitnjače
I Blažeković - 2023 - repozitorij.unizg.hr
Sažetak Jedan od primarnih izazova u liječenju učestalog, no najčešće indolentnog
papilarnog karcinoma štitnjače (PKŠ), je mogućnost ranijeg identificiranja agresivnijih oblika …
papilarnog karcinoma štitnjače (PKŠ), je mogućnost ranijeg identificiranja agresivnijih oblika …
Mutacija V600E gena BRAF i izraženost proteina CPSF2 kao prognostički pokazatelji papilarnoga karcinoma štitnjače
I Ivković - 2022 - dr.nsk.hr
Mnogobrojne studije usmjerene su na utvrđivanje prognostičkih biomarkera koji bi nam
pouzdano izdvojili agresivne oblike papilarnog karcinoma štitnjače već u početnom stadiju …
pouzdano izdvojili agresivne oblike papilarnog karcinoma štitnjače već u početnom stadiju …
Guía para el uso del I131 en pacientes con cáncer diferenciado de tiroides, Sociedad Mexicana de Nutrición y Endocrinología, AC
C ARACELI OCHOA-SOSA… - Revista Mexicana …, 2018 - search.ebscohost.com
El objetivo de la radioterapia con yodo 131 (I131) es eliminar remanente de tejido tiroideo
en sujetos con cáncer diferenciado de tiroides (CDT) para intentar la curación definitiva …
en sujetos con cáncer diferenciado de tiroides (CDT) para intentar la curación definitiva …
[PDF][PDF] An Investigation of Quantitative Accuracy in Preablation I-131 Scans: 7-Pinhole System
T Yu - 2018 - dukespace.lib.duke.edu
Purpose: Early detection and prevention of differentiated thyroid cancer using thyroidectomy
and ablation therapy can reduce disease persistence and recurrence. A preablation I-131 …
and ablation therapy can reduce disease persistence and recurrence. A preablation I-131 …
Imaging modalities in the diagnosis of recurrent or metastatic thyroid cancer
JD Oldan, J Hoang, TZ Wong - Management of Differentiated Thyroid …, 2017 - Springer
The imaging of thyroid cancer takes a multimodality approach, and this is particularly the
case for the workup of recurrent and metastatic disease. Ultrasound can be used to look for …
case for the workup of recurrent and metastatic disease. Ultrasound can be used to look for …
Ekspresija gena za protein visoke pokretljivosti 2 skupine A (HMGA2) u diferenciranim karcinomima i benignim bolestima štitnjače [High-mobility group A protein 2 …
N Dabelić - 2016 - medlib.mef.hr
Zahvaljujem svima koji su mi pomogli tijekom istraţivanja: prof. dr. sc. Josipu Lukaču i doc.
dr. sc. Ivanu Šamiji, predstojniku Kliničkog zavoda za patologiju „Ljudevit Jurak “KBC-a …
dr. sc. Ivanu Šamiji, predstojniku Kliničkog zavoda za patologiju „Ljudevit Jurak “KBC-a …